Scott Foraker
Keine laufenden Positionen mehr
Profil
Scott Foraker is the founder of A2 Biotherapeutics, Inc., which was founded in 2019.
He held the title of President & Chief Executive Officer at A2 Biotherapeutics, Inc. Mr. Foraker also worked at Amgen, Inc. as the Vice President & General Manager-Biosimilars.
Ehemalige bekannte Positionen von Scott Foraker
| Unternehmen | Position | Ende |
|---|---|---|
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Vorstandsvorsitzender | 01.04.2024 |
| AMGEN INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Commercial Services |
